Alpine Global Management’s Genetic Technologies Ltd. GENE Stock Holding History

Alpine Global Management’s Portfolio GENE Stock Details GENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,422	Closed	-$30K	–	124
2018 Q1	$30K	Hold	1,422	–	–	0.01%	110
2017 Q4	$33K	Buy	+1,422	New	+$26.7K	0.01%	182
2017 Q3	–	Sell	-2,111	Closed	-$38K	–	250
2017 Q2	$38K	Buy	+2,111	New	+$44.2K	0.01%	124

Other funds holding GENE

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FANJ

Financial Architects (New Jersey) Marlton, New Jersey $663M AUM 15.53% 1-Year Est. Return

Alpine Global Management's GENE Position: Q2 2018 in Review

Alpine Global Management sold out of Genetic Technologies Ltd. (GENE) in Q2 2018, closing a stake of 1,422 shares — an estimated $30K sold.

Alpine Global Management first reported a position in GENE in Q2 2017 and held it in 3 quarters. The position peaked at $38K in Q2 2017. 14 funds tracked by Wall St. Rank hold GENE as of Q2 2018.

Alpine Global Management reported no remaining Genetic Technologies Ltd. position as of Q2 2018 after selling out during the quarter.
Alpine Global Management sold 1,422 Genetic Technologies Ltd. shares in Q2 2018, an estimated $30K.
Alpine Global Management first reported a position in Genetic Technologies Ltd. in Q2 2017 and held it in 3 quarters.
Alpine Global Management's Genetic Technologies Ltd. position peaked at $38K in Q2 2017.
14 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q2 2018.

Based on Alpine Global Management's 13F filing for Q2 2018, filed 15 Aug 2018.